As of 2026-04-28, the Relative Valuation of bluebird bio Inc (BLUE) is (437.14) USD. This relative valuation is based on P/E multiples. With the latest stock price at 4.97 USD, the upside of bluebird bio Inc based on Relative Valuation is -8895.6%.
The range of the Relative Valuation is (401.19) - (427.34) USD.
Note: valuation result may not be accurate due to the company's negative earnings.
| Range | Selected | |
| Trailing P/E multiples | 19.6x - 26.7x | 23.8x |
| Forward P/E multiples | 16.8x - 20.9x | 19.0x |
| Fair Price | (401.19) - (427.34) | (437.14) |
| Upside | -8172.2% - -8698.3% | -8895.6% |
| Date | P/E |